Chronic hepatitis B virus (HBV) infection is
the most common cause of hepatocellular
carcinoma,1,2 the sixth most common cancer
in the world and one of the leading causes of cancer
death.3 Although a highly effective HBV vaccine
has been available for over 2 decades, HBV
remains a major public health problem. Globally,
350 million people are infected with HBV4 and it is
the leading cause of liver cancer and cirrhosis, and
leads to 3000 deaths annually.5,6 Many of these
deaths are preventable with early diagnosis and
treatment.7
Chronic hepatitis B virus (HBV) infection isthe most common cause of hepatocellularcarcinoma,1,2 the sixth most common cancerin the world and one of the leading causes of cancerdeath.3 Although a highly effective HBV vaccinehas been available for over 2 decades, HBVremains a major public health problem. Globally,350 million people are infected with HBV4 and it isthe leading cause of liver cancer and cirrhosis, andleads to 3000 deaths annually.5,6 Many of thesedeaths are preventable with early diagnosis andtreatment.7
การแปล กรุณารอสักครู่..